Strata Critical Medical, Inc. (SRTA) Stock Analysis — Probabli.AI
AI-powered analysis for SRTA (Strata Critical Medical, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $4.65 · Market cap: $393.2M · AI consensus: Bullish
Strata Critical Medical (SRTA) appears positioned for substantial medium to long-term growth driven by revolutionary medical devices and successful market expansion. Though short-term volatility and competition pose some risks, the strong revenue growth forecast and expert analyst sentiment underpin a generally bullish outlook. The company's ability to leverage innovative products and secure…
Probabilistic 1-Year Outlook
- Bull 5500% · Neutral 3000% · Bear 1500%
- Strata Critical Medical, Inc. (SRTA) has demonstrated strong potential growth in revenue (1780% estimate) and analyst sentiment is very positive with a STRONG BUY consensus. Recent positive developments around FDA…
5-Year Outlook
- Bull 6000% · Neutral 2500% · Bear 1500%
SWOT Highlights
- Strength: Innovative product pipeline including biodegradable stent technology.
- Strength: Robust analyst sentiment and STRONG BUY consensus.
- Risk: High volatility in earnings and share price.
- Risk: Negative avg EPS surprise indicates underperformance versus expectations.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
2 Wall Street analysts rate SRTA a STRONG BUY with a mean price target of $7.63.
Analysis generated Mar 11, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/SRTA.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.